Accéder au contenu
MilliporeSigma

Passer à

SCC367

3dGRO Colon Rectum Intestinal Organoids, Age 23 (Prep ht-208-CR-CR)

Crohns, Colon (Rectum), Age: 23, Male, Mutation: Not Available

Synonyme(s) :

intestinal organoids

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

Changer de vue
ConditionnementRéférenceDisponibilitéPrix
1 vial
Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.
3 790,00 $

A propos de cet article

NACRES:
NA.81
UNSPSC Code:
41106509

3 790,00 $


Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.

Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider


Quality Segment

biological source

human colon (rectum)

packaging

vial of >1500 viable organoids cells

manufacturer/tradename

Millipore

gender

male

growth mode

N/A

technique(s)

cell culture: suitable

application(s)

3D cell culture

control

colon (rectum)

relevant disease(s)

(Crohns)

shipped in

liquid nitrogen

storage temp.

−196°C

Application

  • Viability: >1500 viable organoids/vial
  • Organoid Growth: Pass
  • Cells are tested negative for infectious diseases by a Human Essential CLEAR panel by Charles River Animal Diagnostic Services.
  • Mycoplasma Contamination: Negative
  • STR Profile: Pass

Patient derived organoids (PDOs) are novel in vitro 3D cell models that preserve original tissue physiology and molecular pathology, thus representing a clinically-relevant alternative to traditional 2D cell lines and an effective tool to refine and reduce animal models. PDOs can be derived from adult patient biopsies or resected tissues containing native LGR5+ stem cell populations and cultured within an ECM-rich substrate using specialized organoid media such as L-WRN conditioned media. Adult tissue derived organoids are phenotypically and genetically stable in long term culture, presenting more mature phenotypes compared to iPSC-derived organoids. Importantly, PDOs have shown to be able to predict patient clinical responses to chemotherapeutics.

We are now offering a comprehensive biobank of highly characterized tissue-derived human gastrointestinal organoids from normal and diseased patients. The intestinal organoid biobank contains over 50 highly characterized intestinal organoids from both normal and diseased patients derived from multiple regions of the digestive systems including small intestine (duodenum, ileum), stomach, rectum and colon.

Cell Line Characteristics
  • Sex: Male
  • Age: 23 Years
  • Organ: Colon Rectum
  • Disease: Crohns

Features and Benefits

Cryopreserved patient derived gastrointestinal organoids (PDOs)

Preparation Note

Store in liquid nitrogen. The organoids can be cultured for at least 10 passages after initial thawing without significantly affecting the cell marker expression and functionality.

Legal Information

3dGRO® is a trademark of Merck KGaA, Darmstadt, Germany.
3dGRO® organoids were derived utilizing HUB Organoid Technology.

Subject to local law, this product is intended to be sold for internal in vitro research use only subject to terms and conditions found here: www.sigmaaldrich.com/pdouse. This product may not be re-engineered or copied; used to make derivatives or modifications; used to develop, test, or manufacture a commercial product; used as a component in a commercial product; resold or licensed; used in any clinical applications or trials; or used in humans. A license or limited commercial use agreement is required for use by any for-profit entity, use in services, and use in sponsored academic research. For information regarding any such use, please contact [email protected].
3dGRO is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

Comparer avec des articles similaires

Voir la comparaison complète

Montrer les différences

1 of 1

Cet article
SCC365SCC353SCC335
biological source

human colon (rectum)

biological source

human colon

biological source

human colon (sigmoid)

biological source

human colon

technique(s)

cell culture | mammalian: suitable

technique(s)

cell culture | mammalian: suitable

technique(s)

cell culture | mammalian: suitable

technique(s)

cell culture | mammalian: suitable

relevant disease(s)

(Crohns)

relevant disease(s)

(Crohns)

relevant disease(s)

(Normal Adjacent (Crohns))

relevant disease(s)

(Normal)

application(s)

3D cell culture

application(s)

3D cell culture

application(s)

3D cell culture

application(s)

3D cell culture

storage temp.

−196°C

storage temp.

−196°C

storage temp.

−196°C

storage temp.

−196°C

gender

male

gender

female

gender

female

gender

male


Classe de stockage

10 - Combustible liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents


Contenu apparenté

Un criblage de cibles thérapeutiques et de leads fructueux nécessite des réactifs et du matériel testés, adaptés à la procédure et au haut débit. Trouvez les bons outils pour vos procédés CRO, pharma ou biotech pour le criblage de petites molécules et de produits biologiques, et pour des tests d'immunogénicité robustes afin de garantir la sécurité thérapeutique.

High-throughput reagents for drug target screening and immunogenicity testing.

Voir tous les contenus connexes




Numéro d'article de commerce international

RéférenceGTIN
SCC36704065267124155

Questions

Reviews

No rating value

Active Filters